|
Sudip Bandyopadhyay of Inditrade Capital discusses the positive outlook for the Indian pharma sector following the easing of tariff concerns. He highlights Sun Pharma's promising developments and Glenmark's landmark R&D deal. Bandyopadhyay also notes the expected price hike in the steel industry due to increased global demand, while emphasizing company-specific uncertainties like JSW Steel's Bhushan Steel strategy.
Category:
News and Media
Chakri Lokapriya of LGT Wealth India suggests allocating 20-30% of portfolios to fixed income for stability amidst market volatility. He anticipates a 10-12% Nifty gain for CY2025, contingent on US tariff negotiations, and highlights electronics, semiconductors, and energy as promising sectors. Investors should focus on stocks with strong earnings visibility in a stock picker's market.
Category:
News and Media
State Bank of India's monumental 25,000-crore QIP witnessed overwhelming demand, exceeding four times the offered stock. Attracting bids worth 1.10 lakh crore from around 120 investors, including BlackRock and Marshall Wace, the sale underscores confidence in SBI's growth prospects. The capital raise will bolster SBI's CET 1 ratio, positioning it for future expansion.
Category:
News and Media
All news |
||||||||||||||||||
|